January 25, 2017
IntegriChain launches the Winter ’17 release of its life sciences channel data and analytics suite, including significant usability and user experience enhancements. This new release focuses on improving how users interact with the IntegriChain platform and provides quicker access to key insights, allowing life sciences manufacturers to drive their business decisions faster and more intuitively.
January 9, 2017
Today IntegriChain launched Pharmacy Analytics, a unified suite of payer and channel analytics that addresses critical gaps in Brands’ visibility to prescription pull through in the community pharmacy. Pharmacy Analytics augments the insights delivered in the IntegriChain Pharmacy enriched dataset of competitive market deciles with critical patient access data assets including formulary, claims, and claims and co-pay card redemption data.
November 16, 2016
IntegriChain announces it has reached a significant business milestone with its 10th anniversary of operations. Started in 2006 by aggregating channel data for an initial handful of pharmaceutical manufacturers, now IntegriChain’s wholesale, retail, and specialty channel data and analytics platform delivers business insights that show pharmaceutical suppliers how patients physically and financially access their healthcare products.
October 26, 2016
IntegriChain today announced a strategic partnership with ProMetrics, a leader in longitudinal patient-level data aggregation, to deliver the industry’s first guided analytics solution for specialty channel management, patient service model design, and patient access optimization.
September 6, 2016
IntegriChain announces that Geoffrey Young, a Greater Philadelphia tech veteran, will join IntegriChain’s leadership team as Vice President, Engineering. Young delivers more than 20 years of experience in software engineering in both large organizations and fast-growing young technology leaders including engineering leadership at CloudMine and Monetate.
August 8, 2016
IntegriChain launches a release of its life sciences channel data custom visualization and analytics suite, including significant enhancements to its Demand Visibility and Builder business intelligence offerings. This new release adds major functionality to support power-user reporting and dashboarding capabilities, boosting the simplicity, flexibility, and intuitiveness of delivering analytic insights that enable life sciences manufacturers to leverage channel data to optimize product commercialization activities.
June 6, 2016
IntegriChain launches Revenue Analytics, a suite of enriched channel data offering a unified view of commercial and 340B transactions across all covered entities, sites of care, owned pharmacies, and contract pharmacies. Revenue Analytics allow life sciences manufacturers to minimize revenue leakage and margin erosion resulting from 340B program abuse, orphan drug violations, and missing reverse chargebacks as well as offer trend analytics to understand how patients access products.
May 16, 2016
IntegriChain appoints industry veteran Melissa O’Neal as Senior Director of Customer Operations. O’Neal’s appointment is part of a significant expansion and realignment in IntegriChain’s Operations team to heighten process improvement that maximizes customer value of the company’s data aggregation, applications, and analytics for life sciences manufacturers.
April 19, 2016
IntegriChain launches Specialty Pharmacy Index, a new data service for life sciences manufacturers that helps shape product- or class-specific specialty distribution strategies and identify the most qualified pharmacies to enhance provider experience, patient adherence, and therapeutic outcomes.
April 4, 2016
IntegriChain launched Scorecard Analytics, combining Scorecard data with robust data analysis and visualization capabilities. The enhancement allows Scorecard users to utilize their robust Scorecard data to further maximize pay-for-performance by analyzing channel investment against performance through IntegriChain's powerful query and reporting tools.